Glenmark Pharmaceuticals receives ANDA approval for Nystatin and Triamcinolone Acetonide Ointment

From USFDA

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/ 1 mg per gram, the generic version of Nystatin and Trimacinolone Acetonide Ointment USP, 100,000 units/ 1mg per gram of Taro.

Powered by Capital Market - Live News